The information provided by is not a substitute for professional medical advice, diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of Drugwatch. Sponsored by Wilson and Peterson, LLP with offices at 1050 30th Street NW, Washington, . 20007. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: webmaster@
When we look at the treatment of low testosterone and performance enhancement, the two primary purposes of testosterone use and the two primary methods by-which the effects of testosterone are noted we see there are many overlapping similarities. Truly the only difference in performance enhancement is the doses are higher there by the effects themselves are enhanced. To receive the positive effects of testosterone beyond what you naturally produce it really doesnt matter which form you acquire; Testosterone- Cypionate , Testosterone- Enanthate , Testosterone- Propionate , mixtures such as Sustanon -250 and Omnadren or any other form you can think of, they all contain the same identical testosterone hormone. In the end you simply need the hormone and once you have adequate levels to even beyond you will function and thrive to your desired and needed level; this much is assured.
Patients applied an ANDRODERM 4 mg/day system around 10 . once daily for 14 days, and then were titrated up to 6 mg/day or down to 2 mg/day according to a morning serum testosterone concentration obtained at 6 . on Day 8. Out of 36 patients who entered the study, 31 (86%) patients remained on the 4 mg/day dose, 4 (11%) were titrated downward to 2 mg/day, and 1 (3%) was titrated upward to 6 mg/day based on the Day 8 testosterone concentrations. The one patient that was titrated to 6 mg/day discontinued from the study for a non-safety related reason. Of the patients who were receiving ANDRODERM 5 mg/day prior to study entry (n = 11), 10 remained at 4 mg/day after titration, and 1 was titrated down to the 2 mg/day dose.